Benign prostatic hyperplasia: an approach for the internist.
In benign prostatic hyperplasia, urodynamic testing and the many available drugs and surgical procedures have complicated the issue of what to do for whom. Although the severity of a patient's symptoms and his informed preferences should be the driving forces, specialized tests can help tailor treatment to the individual patient.
Zippe
C D
CD
Department of Urology, Cleveland Clinic Foundation, OH 44195, USA.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000465:Algorithms; D000726:Androgen Antagonists / Q000627:therapeutic use; D003663:Decision Trees; D006801:Humans; D007388:Internal Medicine; D008297:Male; D018579:Patient Selection; D011468:Prostatectomy / Q000379:methods; D011470:Prostatic Hyperplasia / Q000175:diagnosis* / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D012720:Severity of Illness Index; D011795:Surveys and Questionnaires; D014563:Urodynamics
D000317:Adrenergic alpha-Antagonists; D000726:Androgen Antagonists